Imatinib Manufacturers Suppliers Factory

Product Details:

Imatinib, made by Novartis under the brand name Gleevec, is serious areas of strength for a kinase inhibitor used generally in the treatment of explicit sorts of cancer.. It has a spot with a class of drugs known as protein kinase inhibitors and acts by blocking the activity of strange proteins that advance the development of malignant cancer cells.The product is accessible in different structures including oral tablets, capsules, and powder for infusion. As an expert provider of drug unrefined components, Salispharm is committed to giving top notch the product to help different dosage forms, guaranteeing the viability and wellbeing of the last drug items.

Application of Imatinib

Why Choose Us?

Salispharm stands out as a reliable partner in the pharmaceutical industry due to several key advantages:

Mature R&D Team: Our experienced research and development team is committed to continuous innovation and product improvement.
GMP Factory: We work under severe Good Manufacturing Practices (GMP) principles to guarantee the best of our items.
Large Inventory: With a well-managed inventory system, we maintain ample stock of imatinib mesylate 1 mg to meet the demands of our customers.
Complete Certificates: We hold various certifications including FDA-Salis, HALAL, ISO, CCRE5, organic USDA, organic, and EU Organic, ensuring compliance with international quality and safety standards.
OEM Service: Salispharm offers comprehensive OEM services, supporting various dosage customization options and the sale of finished products under private labels.
Fast Delivery: We focus on efficiency in our logistics operations to guarantee opportune conveyance of orders to our clients.
Secure Packaging: Our products are securely packaged to prevent damage during transportation and storage.

COA of Imatinib:

ITEM	SPECFICATION	RESULTS
Appearance	White or almost white powder	almost white powder
Identification	By HPLC	Complies
Water	≤2.0%	0.33%
Heavy Metals	≤20ppm	Complies
Assay	98.0%~102.0%	99.0%
Residue On Igintion	≤0.1%	0.008%
Related Impurity	Impurity F:S30PPM	16PPM
	Single Impurity:≤0.5%	0.004%
	Total Impurity:≤1.0%	0.008%
Conclusion:	Conform with enterprise specification.

Use of Imatinib:

The product is demonstrated for the therapy of different sorts of malignant growth, including:

Chronic Myeloid Leukemia (CML):The product is fundamentally compelling in the therapy of recently analyzed and constant stage CML, as well as sped up and impact stage CML.
Acute Lymphoblastic Leukemia (ALL): It is used in the treatment of Philadelphia chromosome-positive ALL, in combination with other chemotherapy agents.
Gastrointestinal Stromal Tumors (GIST): The product is viewed as the first-line treatment for unresectable or metastatic Substance.
Dermatofibrosarcoma Protuberans (DFSP): It is indicated for the treatment of unresectable, recurrent, or metastatic DFSP.

The product works by hindering explicit tyrosine kinases, including BCR-ABL, c-KIT, and PDGF-R, which are related with the development and multiplication of malignant growth cells. The dose and span of therapy might fluctuate relying upon the kind and phase of disease, as well as individual patient variables. It is vital with adhere to the endorsing doctor's directions and comply to the suggested dosage regimen.

Application of Imatinib:

Imatinib finds applications in different clinical settings including:

Oncology Clinics: The product is a foundation in the therapy of ongoing myeloid leukemia, intense lymphoblastic leukemia, gastrointestinal stromal cancers, and dermatofibrosarcoma protuberans.
Hospitals: It is broadly utilized in clinic settings for both ongoing and short term therapy of malignant growth patients.
Research Institutions: The product is also utilized in research institutions for studying the molecular pathways involved in cancer development and exploring novel treatment strategies.

Dosage and Usage:

The suggested measurements of imatinib mesylate 1 mg changes relying upon the sort of malignant growth being dealt with and the patient's clinical history. It is typically regulated orally once daily with a meal and a full glass of water. The measurement might be changed by the medical care supplier in view of individual reaction to therapy and the event of unfriendly responses. It means a lot to gulp down the tablets or capsules, without squashing or biting them. Patients ought to keep taking the product however long endorsed, even if they feel good, to accomplish the best treatment results.

Quality Standards and Certification:

Salispharm is focused on keeping up with the best expectations of value and wellbeing for every one of its items. Our imatinib mesylate capsules is produced in consistence with the accompanying affirmations:

FDA-Salis: Ensuring compliance with the regulations set forth by the U.S. Food and Drug Administration (FDA).
HALAL: Meeting the requirements of Islamic dietary laws and regulations.
ISO: Sticking to the principles framed by the International Organization for Standardization (ISO) for quality administration frameworks.
CCRE5: Complying with the regulations of the China Chemicals Registration Center.
Organic USDA, Organic, EU Organic: Certifying organic production methods and ingredients according to the standards set by the respective regulatory bodies.

product-1-1

Packaging and Transportation:

Our imatinib mesylate capsules products are carefully packaged in accordance with industry standards to ensure product integrity and safety during transportation and storage. We use solid packaging materials that give assurance against dampness, light, and physical harm. Our logistics team is experienced in handling pharmaceutical products and ensures prompt delivery to customers worldwide.